Trump Media to sell early access to key social posts

This post was originally published on this site.

Trump Media to sell early access to key social posts

ByFrancisco Velasquez

Business reporter
  • Published

Trump Media & Technology Group, which owns Truth Social, is launching a paid service to give Wall Street firms high-speed access to its most influential posts, though it is not clear if the paid service will include President Trump’s posts.

Launching 1 August, instant updates will be delivered from key accounts, it said.

The company behind the app hopes it will create a steady new source of money for the firm which is currently loss-making.

It is likely aimed at financial traders who want to see market-moving news fast. Trump’s social media posts often cause sudden swings in global markets, especially when he writes about trade and tariffs. For firms, a delay of even seconds can be costly.

Until now, banks and traders had to monitor the app manually. The new system will send posts directly to paying clients.

”Markets already move on Truth Social posts“, said Kevin McGurn, the interim boss of Trump Media, adding that the service will create a steady profit.

The service will run 24 hours a day, seven days a week.

The company, which launched its social media app in 2022, said some firms have been copying its data for months without permission.

McGurn warned that Trump Media will soon block these methods, forcing firms to buy the official feed instead.

While other social media networks already sell data, the move highlights the unique overlap between Trump’s private business and his public role as president.

Hot this week

The Papers: ‘Spending warning to Burnham’ and ‘Only 693 days till Euros’

The IMF gives a "spending warning to Burnham" and England eyes the Euros after its World Cup loss - Friday's front pages.

Blasts reported in Iran as US launches new wave of strikes

Iran says US strikes hit bridges in the country in an apparent escalation, while the US boards a ship in the Strait of Hormuz.

Kit Connor and Joe Locke: ‘Making a film like Heartstopper will forever be important’

The Netflix movie brings Alice Oseman's popular screen adaptation to a conclusion.

Targeted prostate cancer treatment cuts risk of side effects, study suggests

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img